Zenith Bank FY: 2017 Earnings: Resilient Performance… A Clear Case of Undervaluation

Mr. Peter Amangbo, Group MD/CEO, Zenith Bank Plc

Zenith Bank Plc released its FY: 2017 earnings result on the floor of the exchange on Monday and in line with expectation, Zenith’s performance was largely impressive.

Gross earnings surged 46.7% Y-o-Y to N745.2bn. The Bank’s Interest income rose 23.4% Y-o-Y from N384.6bn in FY: 2016 to N474.6bn in FY: 2017 following increased yield on loans and advances (from 10.9% in FY: 2016 to 11.8% in FY:2017) while Non-interest income surged 119.2% Y-o-Y to N270.6bn in FY:2017 from N123.4bn in the prior year, majorly due to the significant gains recorded from trading activities (especially Treasury Bills  and Derivatives trading). As noticed in 2017, more Banks seem to be focusing on trading activities to boost income given the attractive yield environment. This has been particularly true for Zenith which consistently recorded average quarterly trading income of N39.9bn between Q1:2017 to Q4:2017 from 2016 corresponding quarterly average of N7.1bn.

We believe this is an income line that has come to stay as the Bank takes advantage of opportunities in the market. Zenith was also able to maintain its drive to optimize cost as Cost to Income Ratio (CIR) moderated to 42.9% from 48.0% in FY: 2016 despite a 30.0% increase in OPEX (from N174.5bn to N226.9bn).

Accordingly, PAT advanced 37.2% Y-o-Y to N177.9bn from N129.7bn in the prior year while RoAE improved to 23.4% from 20.0% in the prior year. A final dividend of N2.45 (N0.25 paid for H1:2017) was proposed for the period, translating to an implied dividend yield of 7.9%. Our Compelling Investment Thesis for Zenith The resilience of Zenith is clearly demonstrated in its FY: 2017 performance and we have a positive outlook on future earnings in 2018 and beyond. In our view, the dividend yield (7.9%) on the stock is quite attractive given the current realities in the market and this presents a good opportunity for investors interested in dividend paying stocks. Furthermore, on a valuation basis, considering the pre-earnings announcement P/BV of 1.5x and current P/BV multiple of 1.2x, we believe the stock is currently undervalued and presents an attractive entry opportunity.

In a scenario in which the stock trades at the pre-earnings release P/BV, we envisage an implied price of N39.25 on ZENITH which presents an upside opportunity of 26.8% against a price of N31.00 (13/03/2018).

Against the backdrop of our expectation of positive performance in 2018 as well as the current attractive pricing on the stock, we believe it is Open Season on ZENITH! and investors should be on the hunt for the Stock.

spot_img
spot_img
spot_img
spot_img
spot_img

Hot this week

Stanbic IBTC Bank Nigeria PMI: Marked Growth of New Orders Seen Again in July

Growth was maintained in the Nigerian private sector during...

NAICOM: 43 Insurance/Re Firms Scale Recapitalisation Hurdle, 8 Awaiting Final Verification

The National Insurance Commission, today announced the successful completion...

NLNG Unveils 11 Nominees for The Nigeria Prize for Creative Arts

The first-ever nominees for The Nigeria Prize for Creative...

CBN Lists Five Strategies to Drive Next Stage of Fintech Growth in Nigeria

L-R:  Mr. Emmanuel Ovaga, MD/CEO, PufferPay Ltd; Sola Longe-Okenimkpe,...

NGX Chair: Exchange Adopting Fintech, Digital Solutions to Expand Market

L-R:  Mr. Emmanuel Ovaga, MD/CEO, PufferPay Ltd; Sola Longe-Okenimkpe,...

Topics

Orange Completes Acquisition Tigo in DR Congo

Less than three months after signing an agreement with...

NDIC, Others Harp on Banks, Fintech Collaboration Towards Nigeria’s $1trn Economy

For Nigeria to achieve the $1trillion Gross Domestic Product...

Linkage Assurance Names Daniel Braie Acting MD/CEO

The Board of Directors, Linkage Assurance Plc has named...

New WAIFEM DG, Baba Musa, Plans to Build Next Generation of Economic Leaders

The Director General of the West African Institute for...

Kenya, 1st Country to Launch ‘Novartis Access’ for Affordable Health

Novartis has announced the launch of Novartis Access in Kenya, the first country to benefit from a portfolio of 15 affordable medicines to treat cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The Novartis portfolio is being offered to the Kenyan government, non-governmental organisations and other public-sector healthcare providers for USD 1 per treatment, per month.

IATA: Passenger Airport Charges Double in 10 Years

The International Air Transport Association (IATA) calls on the...

Rising Stars Shine at Ecobank’s National Schools Team Chess Championship

Right: Vice President, Nigeria Chess Federation, Prince Adeyinka Adewole;...

NSE Bloomberg CEO Roundtable 2018

L – R: Oladele Afolabi, Director, Portfolio Management, Debt Management...
spot_img

Related Articles

Popular Categories

spot_imgspot_img